Seamlessly automating complex, time-consuming, and error-prone regulatory and medical writing tasks.
We streamline the process, reducing stress and human error, so our clients can focus on accelerating life-saving treatments to market.
We are heartbroken to announce the passing of our President and Chief Technical Officer, Jamie Hijmans, who died on October 20, 2024. He served as the visionary and guiding force of Global Exponential Technologies (GxT) since the company's founding in 2022, demonstrating exceptional leadership, vision, and dedication.
Under Jamie's stewardship, GxT was founded and developed into a full stack software development company responsible for the development and launch of several stand-alone products, including: ADDM Trend™, SmartComplaints™, and RegWriter™. Jamie was a thought leader in the development and implementation of AI applications to support regulatory submissions for the medical device and biopharma industries and will be sorely missed for his unique ability to bridge the gap between the rapid innovations in software automation and industry's regulatory needs.
Jamie is survived by his wife Kyler, daughter Pax, father Marty, and brother Carey. Our thoughts are with his family during this difficult time.
We appreciate your understanding and support as we navigate this profound loss.
Meet the GxT team, a perfect mix of life science, regulatory, and cutting-edge software experience.